Why is Senores Pharma. falling/rising?

As of 18-Jul, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 625.60, reflecting a change of 3.9 (0.63%) upward. The stock has shown strong performance recently, with a 2.63% increase over the past week and a significant 17.26% rise over the last month, outperforming the Sensex, which has only increased by 0.38% in the same period. Today's performance indicates that the stock has outperformed its sector by 1.18% and has been gaining for the last two days, accumulating a total return of 1.73%. Despite these positive indicators, there are concerns regarding falling investor participation, as the delivery volume has decreased significantly by 62.37% compared to the five-day average. The company benefits from a low debt-to-equity ratio and impressive long-term growth rates in net sales and operating profit, which support its recent price movement.
Broader market context shows that while Senores Pharmaceuticals has been performing well, the overall market, represented by the Sensex, has seen a decline of 0.90% over the past week. This contrast highlights the stock's resilience in a challenging market environment. However, there are signs of caution, particularly with institutional investors reducing their stakes by 0.65% in the last quarter, which may indicate a lack of confidence among more sophisticated market participants. This could potentially impact the stock's future performance, despite its current upward trend and strong fundamentals.